$5.94
-0.410 (-6.46%)
At Close: Jun 03, 2026
Absci (NASDAQ:ABSI) & Anavex Life Sciences (NASDAQ:AVXL) Financial Analysis
10:04am, Tuesday, 07'th Dec 2021 Dakota Financial News
Absci (NASDAQ:ABSI) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Analyst Ratings This is a summary of current recommendations and price targets for Absci and []
Head-To-Head Comparison: iSpecimen (NASDAQ:ISPC) vs. Absci (NASDAQ:ABSI)
08:34am, Monday, 06'th Dec 2021 Transcript Daily
iSpecimen (NASDAQ:ISPC) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Valuation and Earnings This table compares iSpecimen and Abscis gross revenue, earnings per share (EPS) and valuation. []
Absci (NASDAQ:ABSI) vs. AIkido Pharma (NASDAQ:AIKI) Head to Head Review
05:12pm, Friday, 03'rd Dec 2021 Dakota Financial News
Absci (NASDAQ:ABSI) and AIkido Pharma (NASDAQ:AIKI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings. Valuation & Earnings This table compares Absci and AIkido Pharmas top-line revenue, earnings per share (EPS) []
Head-To-Head Contrast: Charles River Laboratories International (NYSE:CRL) vs. Absci (NASDAQ:ABSI)
12:54pm, Sunday, 28'th Nov 2021 Dakota Financial News
Charles River Laboratories International (NYSE:CRL) and Absci (NASDAQ:ABSI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Charles River Laboratories International and Abscis net margins, return on equity []
Contrasting Absci (NASDAQ:ABSI) and Luna Innovations (NASDAQ:LUNA)
10:18am, Tuesday, 23'rd Nov 2021 Dakota Financial News
Luna Innovations (NASDAQ:LUNA) and Absci (NASDAQ:ABSI) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Profitability This table compares Luna Innovations and Abscis net margins, return on equity and return []
PPD (NASDAQ:PPD) versus Absci (NASDAQ:ABSI) Head to Head Analysis
04:20pm, Monday, 22'nd Nov 2021 Transcript Daily
Absci (NASDAQ:ABSI) and PPD (NASDAQ:PPD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Valuation & Earnings This table compares Absci and PPD’s gross revenue, earnings per share (EPS) and valuation. Gross […]
Comparing iSpecimen (NASDAQ:ISPC) and Absci (NASDAQ:ABSI)
02:36pm, Friday, 19'th Nov 2021 Transcript Daily
iSpecimen (NASDAQ:ISPC) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability. Valuation & Earnings This table compares iSpecimen and Abscis revenue, earnings per share (EPS) and valuation. Gross []
Absci (NASDAQ:ABSI) Lowered to Hold at Zacks Investment Research
07:48am, Thursday, 18'th Nov 2021 Transcript Daily
Absci (NASDAQ:ABSI) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The companys Creation(TM) Platform involved in discovery of novel []
Absci (NASDAQ:ABSI) Downgraded to Hold at Zacks Investment Research
09:36pm, Tuesday, 16'th Nov 2021 Dakota Financial News
Absci (NASDAQ:ABSI) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The companys Creation(TM) Platform involved in discovery of novel []
(ABSI) Alert: Did You Lose Money on Your Absci Corporation Investment? Contact Johnson Fistel Regarding Investigation
09:14pm, Monday, 15'th Nov 2021 Intrado Digital Media
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Absci Corporation (Absci) (NASDAQ: ABSI) and its officers and directors for violations of federal securities laws.
Absci Corporation (ABSI) CEO Sean McClain on Q3 2021 Results - Earnings Call Transcript
07:32am, Sunday, 14'th Nov 2021
Absci Corporation (ABSI) CEO Sean McClain on Q3 2021 Results - Earnings Call Transcript
Contrasting Absci (NASDAQ:ABSI) & iSpecimen (NASDAQ:ISPC)
06:22am, Sunday, 14'th Nov 2021 Dakota Financial News
iSpecimen (NASDAQ:ISPC) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. Analyst Recommendations This is a summary of current recommendations and price targets for iSpecimen and Absci, as []
Biotech company Absci, which recently went public, cuts ribbon on new HQ in Vancouver, Wash.
12:29pm, Wednesday, 03'rd Nov 2021
Absci cut the ribbon on its new headquarters in Vancouver, Wash.
Absci to Report Third Quarter Financial Results on November 9, 2021
04:05pm, Thursday, 14'th Oct 2021
VANCOUVER, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic
FMR LLC's Top 5 Buys in September
04:10pm, Tuesday, 12'th Oct 2021
FMR LLC, the Boston-based asset management company commonly known as Fidelity, disclosed this month that its top-five trades during September included new buys in Toast Inc. ( TOST , Financial), Graph
Sign In
Buy ABSI